Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Luca Vinci(University Medical Center Freiburg), Ayami Yoshimi(University of Freiburg), Miriam Erlacher(University Medical Center Freiburg), Herbert Pichler(St Anna Children's Hospital), Dominik Turkiewicz(Skåne University Hospital), Franco Locatelli(Bambino Gesù Children's Hospital), Tania Nicole Masmas(Copenhagen University Hospital), Marek Ussowicz(Wroclaw Medical University), Jan Starý(Charles University), Brigitte Strahm(University Medical Center Freiburg), Jochen Buechner(Oslo University Hospital), Owen Smith(Trinity College Dublin), Dirk Lebrecht(University Medical Center Freiburg), Riccardo Masetti(Azienda USL di Bologna), Marco Zecca(Policlinico San Matteo Fondazione), Peter Noellke(University of Freiburg), Ivana Boďová(National Institute of Cardiovascular Diseases), Roland Meisel(Düsseldorf University Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Peter Lang(STZ eyetrial), Michael Dworzak(St. Anna Children's Cancer Research Institute), Barbara De Moerloose(Ghent University Hospital), Henrik Hasle(Aarhus University Hospital), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Gudrun Göhring(Medizinische Hochschule Hannover), Kirsi Jahnukainen(University of Helsinki), Válerie de Haas(Princess Máxima Center), Tayfun Güngör, Krisztián Kállay, Charlotte M. Niemeyer(University of Freiburg), Christian Flotho(University Medical Center Freiburg)
Cited by 12
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
|Blood|2004|1.6k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738